Mario Guralnik
No más puestos en curso
Perfil
Dr. Mario Guralnik is Head-US Clinical Operations at Ora Bio Ltd.
Dr. Guralnik was previously employed as a Manager-Clinical Affairs by Amgen, Inc.
He received his doctorate degree from the University of California, Los Angeles.
Antiguos cargos conocidos de Mario Guralnik.
| Empresas | Cargo | Fin |
|---|---|---|
Ora Bio Ltd.
 Ora Bio Ltd. Pharmaceuticals: MajorHealth Technology Ora Bio Ltd. engaged in the repositioning of existing drugs for second-use applications. The firm develops its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration. The company was founded by Yossi Israeli and Amichai Baron in June 2005 and is headquartered in Nazareth Illit, Isreal. | Corporate Officer/Principal | - |
| AMGEN INC. | Director Técnico/Científico/I+D | - |
Formación de Mario Guralnik.
| University of California, Los Angeles | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Ora Bio Ltd.
Ora Bio Ltd. Pharmaceuticals: MajorHealth Technology Ora Bio Ltd. engaged in the repositioning of existing drugs for second-use applications. The firm develops its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration. The company was founded by Yossi Israeli and Amichai Baron in June 2005 and is headquartered in Nazareth Illit, Isreal. | Health Technology |
- Bolsa de valores
- Insiders
- Mario Guralnik
